BioSpace News Archive

Deals

Takeda Eyes China Drug Market as its Next Big Opportunity Following Shire Deal

The Chinese biopharma market is booming as more and more companies eye breaking into that rich market. Christophe Weber, chief executive officer of pharma giant Takeda, views its China programs as its second-biggest business behind the United States.

July 19, 2018
·
2 min read
·
Alex Keown
Business

IFM Therapeutics Launches Subsidiary IFM Tre With $31 Million and Focus on Inflammatory Diseases

This morning IFM Tre, a subsidiary of IFM Therapeutics, launched with $31 million in the bank and a focus on developing a suite of different NLRP3 antagonists.

July 19, 2018
·
2 min read
·
Alex Keown
Biotech Beach

July 20 Research Roundup: PARPi and Rare Cancers, “Pleasure” Brain Chemicals and Cancer Suppression, Omega-3 and More

There are plenty of great scientific research stories out this week. Here’s a look at just a few of them.

July 19, 2018
·
4 min read
·
Mark Terry
FDA

Gottlieb Slams Pharma, Launches Biosimilars Pathway

In a speech given at the Brookings Institution preceding the release of the U.S. Food and Drug Administration (FDA)’s Biosimilars Action Plan, FDA Commissioner Scott Gottlieb unloaded on big pharma.

July 19, 2018
·
3 min read
·
Mark Terry
Business

Gilead’s Kite and Netherlands’ Gadeta Ink Strategic T-Cell Collaboration

Kite, a Gilead company based in Santa Monica, California, signed an agreement with Utrecht, Netherlands-based Gadeta BV. The companies will work on discovering and developing novel cancer immunotherapies based on gamma-delta T-cell receptors (TCRs).

July 19, 2018
·
2 min read
·
Mark Terry
Business

Galapagos and MorphoSys Ink Deal with Novartis for $1.111 Billion+

Galapagos and MorphoSys signed an exclusive development and commercialization deal with Swiss-based Novartis.

July 19, 2018
·
2 min read
·
Mark Terry
Business

Buffett, Bezos and Dimon’s Healthcare Boss Hits the Road on Listening Tour

Atul Gawande is heading out to hold one-on-one meetings with employees of a new healthcare venture to get a handle on their healthcare needs, challenges and concerns.

July 19, 2018
·
3 min read
·
Mark Terry
Drug Development

Patient Death: Mersana Shares Plunge

Shares of Mersana Therapeutics have plunged nearly 40 percent this morning after the company announced the FDA placed a partial clinical hold on its Phase I antibody drug conjugate XMT-1522 following the death of a patient.

July 19, 2018
·
2 min read
·
Alex Keown
Biotech Bay

Karius Liquid Biopsy Accurately Detects Invasive Fungal Infections

Some diagnostics testing for infectious diseases can be quite invasive and uncomfortable for a patient. Now though, a new form of test is available that can mitigate the need for those invasive tests.

July 19, 2018
·
3 min read
·
Alex Keown
Pharm Country

Two Tech Companies Develop Platforms to Help In the Fight Against Mental Illness

Over the years there have been questions surrounding the efficacy of some medications used to treat mental health issues. Last year a Harvard professor argued on CBS’ 60 Minutes that there was little difference between a psychiatric drug and a placebo.

July 19, 2018
·
3 min read
·
Alex Keown